Fortnightly Review: Reflex sympathetic dystrophyBMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6995.1645 (Published 24 June 1995) Cite this as: BMJ 1995;310:1645
- Elisabeth Paice, consultant rheumatologista
Reflex sympathetic dystrophy indicates the syndrome of a painful, swollen, discoloured, abnormally sensitive, and useless extremity, usually developing after trauma, and first described as a complication of gunshot wounds in the American Civil War.1 Even after 130 years, we still cannot agree what to call it, do not understand what causes it, and do not know how best to treat it.
The term reflex sympathetic dystrophy, or the reflex sympathetic dystrophy syndrome, seems to be preferred by those writing in English, algodystrophy by those writing in French, and Sudeck's atrophy by those writing in German or referring to a late atrophic phase of the condition. Definitions and clinical criteria abound.2 The International Association for the Study of Pain produced the following definition: “continuous pain in a portion of an extremity after trauma which may include fracture but does not involve a major nerve, associated with sympathetic hyperactivity.”3 Kozin, whose criteria for diagnosis are most widely quoted, considered it essential to recognise that pain may be the only manifestation of the reflex sympathetic dystrophy syndrome and also included patients with vasomotor or sudomotor changes without pain or tenderness as possibly having the syndrome.4 The consensus report of an ad hoc committee of the American Association for Hand Surgery considered that the term reflex sympathetic dystrophy was used too loosely to be valuable and errors of under and over diagnosis occurred.5 It agreed on the following definition: a pain syndrome in which the pain is accompanied by loss of function and evidence of autonomic dysfunction (figs 1-3).
Reflex sympathetic dystrophy usually follows trauma, however trivial, or a variety of other triggers, such as stroke, shingles, and myocardial infarction.4 It has been suggested that reflex sympathetic dystrophy results from an initial vasomotor reflex spasm, occurring after injury, followed by a loss of vascular tone leading to vasodilatation and rapid bone resorption. Increasing immobility then leads to decreased circulation, leading eventually to fibrosis and shortening of ligaments.6 Various theories have been offered to explain the vasomotor changes, including an abnormality in the central nervous system within the internuncial neuron pool of the substantia nigra where a “self exciting system” develops.7 Others have suggested abnormalities of the peripheral nervous system, with abnormal synapses between efferent sympathetic nerves and afferent sensory nerves, or sensitised peripheral nerves discharging spontaneously.8
The view that the condition is caused by an abnormality of the sympathetic system is widely challenged, and a variety of other explanations have been offered.9 If there is increased sympathetic activity in the affected limb it should be possible to find increased concentrations of adrenaline or noradrenaline. It seems that the reverse is the case. In 26 patients with features of reflex sympathetic dystrophy, venous blood was collected from painful and unaffected limbs and levels of plasma adrenaline and noradrenaline and its intracellular metabolite, 3,4-dihydroxyphenylethyleneglycol, were measured. Plasma concentrations of the metabolite were lower on the painful side. Concentrations of plasma noradrenaline were also lower on the painful side in patients with abnormal skin sensitivity and in those with hyperhidrosis in the affected hand or foot. These findings suggest that sweating and changes in peripheral blood flow in reflex sympathetic dystrophy may result from supersensitivity to sympathetic neurotransmitters rather than overreactivity of the sympathetic system.10 Other studies showed that vasoconstrictor tone was reduced rather than increased in symptomatic areas,11 and resting sympathetic discharge was not increased.12 13 Susceptible people may have a problem with natural opioid modulation. After injury there is normally an increased output of opioids from regional sympathetic ganglia, which prevents excessive autonomic activity in an injured limb. If this fails, dystrophic changes may occur either because of passive complications of disuse associated with pain or as a result of more active processes.14
Psychological disturbance has been postulated as a predisposing factor, with reflex sympathetic dystrophy patients described as psychologically peculiar.15 16 In 42 patients, investigators observed different frequency distributions for the personality traits self satisfaction, rigidity, and somatisation than in controls.17 Others have criticised such studies because of the lack of controlled or prospective data.18
Ochoa makes an impassioned case for the “demystification” of the reflex sympathetic dystrophy syndrome and acceptance that the condition has little to do with the sympathetic nervous system, that sympathetic blockade works only by a powerful placebo effect, and that most patients qualifying for the descriptive diagnosis of reflex sympathetic dystrophy have a distinct, potentially treatable neuropsychiatric disorder. He describes the diagnosis of reflex sympathetic dystrophy as a dangerous diagnosis to make, condemning the patient to ultimate therapeutic failure after an initial bonanza, or to migration to another part of the body.19
Three stages of severity have been described.20 Stage I consists of pain out of proportion to any injury, abnormal sensitivity, swelling, vasomotor and sudomotor changes, and diffuse osteoporosis. Stage II is characterised by persistence of pain and disability with increasing dystrophy. Stage III is marked by skin and subcutaneous tissue atrophy and contractures. However, a study of 829 patients referred over eight years to a tertiary referral centre was not able to confirm this chronological progression21 but found that patients could be divided into “warm” or “cold” on the basis of relative skin temperature in the affected limb, and the longer they had reflex sympathetic dystrophy the more likely they were to have a cold limb. Despite this, 13% of patients examined very early in the condition had a cold limb, and warm limbs were found in patients who had had reflex sympathetic dystrophy for many years. Tissue atrophy was a rare and late finding in this study. The authors devised their own criteria for inclusion, consisting of unexplained pain, vasomotor changes, and aggravation by use. Requiring the presence of osteopenia would have led to rejection of 70% of their cases.
It usually follows trauma, however trivial
Swelling, discoloration, temperature changes, abnormal sensitivity, sweating, and loss of function are typical features of the syndrome
Radiographs usually show osteopenia of the affected part
If treatment is neglected, permanent disability may result
Early recognition, pain control, and mobilisation are associated with a good prognosis
Large scale controlled trials of the invasive treatments in common use have not been carried out
In a series of 70 children with reflex sympathetic dystrophy, the average age was 12.5, girls out-numbered boys in a ratio of almost 6:1, and a leg was affected in 61 cases. The average time from the initial injury to the diagnosis was one year. Conservative treatment with physical therapy, transcutaneous electrical nerve stimulation, and psychological therapy was effective in 40 patients. Sympathetic blocks were helpful for 28 of 37 patients treated. Thirty eight of the 70 patients in the series continued to have some degree of residual pain and dysfunction.22 The most important factor in treatment may be mobilisation.23 Children are less likely to report antecedent trauma, and less likely to have osteopenia.24
Sudeck described the radiographic changes of spotty osteopenia (figs 4 and 5) in 1900.25 The osteoporosis is greater than that which would be expected from disuse alone.26 In a prospective study of 60 consecutive patients who had suffered unilateral fractures of the tibial shaft, 18 patients showed signs of reflex sympathetic dystrophy at the time of bone union. Patients with reflex sympathetic dystrophy lost significantly more bone mineral density than did those without. The degree of loss was independent of type of management and of the time to fracture union.27 Radioisotope bone scanning may be helpful in diagnosis. Adults with reflex sympathetic dystrophy have a characteristic delayed bone scan pattern consisting of diffusely increased uptake with juxta-articular accentuation, but in children decreased uptake at the symptomatic site is more common.28 Three phase technetium bone scan was used in the investigation of 63 patients with unexplained arm pain. Twenty six per cent of these were found to have a definite or probable reflex sympathetic dystrophy on Kozin's criteria. The predictive value of the test was assessed retrospectively. The three hour delayed image showed a sensitivity of 50%; specificity of 92%; positive predictive value of 67%, and negative predictive value of 84%. This was not improved when data from the blood flow or pool phase were used. Duration of symptoms less than six months or age more than 50 years substantially increased the sensitivity and positive predictive value of the scan.29 Thermography offers a sensitive method for detecting and recording temperature differences between affected and unaffected limbs.
Most authors emphasise the importance of physiotherapy in the prevention and treatment of the disease. A study of 54 patients with reflex sympathetic dystrophy compared exercises and cryotherapy either with or without galvanic stimulation, and reported a significant therapeutic effect in both treatment groups.30 Two thirds of 489 patients who had received physiotherapy for reflex sympathetic dystrophy reported temporary exacerbation in the hours following treatment,24 No placebo-controlled studies of physiotherapy have been performed.
Sympathetic blockade has been the most popular therapeutic approach since the 1930s,31 initially induced surgically and later by intravenous guanethidine blockade.32 Controlled studies of any size are few. The efficacy of guanethidine versus reserpine was compared in 12 patients, 10 of whom had previous stellate or lumbar sympathetic blocks, in a placebo controlled, double blind, cross over study. Each patient successively received 20 mg guanethidine in 50 ml 0.5% lignocaine, 1.25 mg reserpine in 50 ml 0.5% lignocaine, and 50 ml 0.5% lignocaine with a one week interval between drugs, followed by continued treatment with whichever treatment had seemed the most effective. Follow up lasted for a minimum of six months. Changes in pain intensity for the first three days did not differ significantly among guanethidine, reserpine, and control groups. Pain was relieved for two to 14 months in two patients receiving reserpine, one receiving guanethidine, and none receiving lignocaine. None of the patients experienced permanent relief. No difference was found between reserpine and guanethidine.33
A placebo controlled study of bretylium (a guanethidine-like drug which inhibits the release of noradrenaline from adrenergic nerve endings) was performed on 12 patients with reflex sympathetic dystrophy who received transient pain relief from stellate ganglion blocks or lumbar sympathetic blocks. Each patient received two control treatments (0.5% lignocaine) and two treatments with 0.5% lignocaine and bretylium 1.5 mg/kg in a randomised, double blind fashion. Five patients failed to complete. Bretylium and lignocaine provided more than 30% pain relief for a mean of 20.0 (SD 17.5) days, whereas lignocaine alone provided relief for only 2.7 (3.7) days (Mann-Whitney U test, P<0.001).34
Ketanserin was assessed against placebo in a double blind, cross over study of 16 patients with chronic peripheral burning pain. Nine of these had signs of reflex sympathetic dystrophy. All patients underwent four intravenous regional treatments, two with ketanserin and two with placebo. In those patients with reflex sympathetic dystrophy, ketanserin and not placebo provided sustained pain relief. In patients who did not fulfil the criteria for reflex sympathetic dystrophy no significant relief was seen with placebo or ketanserin.35
Uncontrolled studies abound, offering subjective and objective evidence of improvement with a variety of treatments.36 37 38 39 A retrospective review of 199 patients with sympathetic reflex dystrophy of the foot compared a variety of treatments; calcitonin (177 patients) improved or cured 62% of those treated. Regional sympathetic blockade with guanethidine (49 patients) provided 80% improvement or cure. All patients in this study were cured, 75% in less than a year. Normal activities were possible five months after the end of treatment in both groups. Neither psychological disturbance or work related injury affected the outcome.40 A total of 513 regional intravenous guanethidine blocks were carried out in 125 cases of reflex sympathetic dystrophy; a positive result occurred in 90 after a mean of 4.5 (1.7) blocks.41
Most authors emphasise the importance of early, confident, multidisciplinary treatment of reflex sympathetic dystrophy, a condition which untreated can lead to devastating long term disability. Unfortunately we have little objective evidence on which to base a rational treatment plan. It is surely time for large multicentre prospective placebo controlled studies to look at the effect of early mobilisation after fracture, the various forms of physiotherapy, and the variety of treatments available.
Thermography was performed by Mr Kevin Howell at the Royal Free Hospital Rheumatology Research Unit. Other photographs were prepared by the photography department of the Whittington Hospital NHS Trust.